JRCT ID: jRCT1010220039
Registered date:28/02/2023
optimization of MSC production
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | spinal cord injury |
| Date of first enrollment | 28/02/2023 |
| Target sample size | 50 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | cell collection rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Patients newly admitted to Sapporo Medical University Hospital to receive Stemirac Injection who are able to obtain consent will be eligible. The scope of the study will include patients undergoing treatment with STEMILAC Injection for whom it was determined that it is possible to collect bone marrow safely. |
| Exclude criteria | 1. Cases in which consent to participate in the research could not be obtained. 2. Cases in which it is considered difficult to collect specimens safely. |
Related Information
| Primary Sponsor | Sasaki Masanori Masanori |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Masanori Sasaki |
| Address | S1W17, Chuo-ku, Sapporo, Hokkaido Hokkaido Japan 060-8556 |
| Telephone | +81-116112111 |
| msasaki@sapmed.ac.jp | |
| Affiliation | Sapporo Medical University |
| Scientific contact | |
| Name | Masanori Masanori Sasaki |
| Address | S1W17, Chuo-ku, Sapporo, Hokkaido Hokkaido Japan 060-8556 |
| Telephone | +81-116112111 |
| msasaki@sapmed.ac.jp | |
| Affiliation | Sapporo Medical University |